Riverside’s private equity portfolio

Portfolio

Return to Portfolio Search

Crioestaminal

Crioestaminal is a pioneer and leader in Portugal in isolation and cryopreservation of stem cells from umbilical cord blood. If necessary, these cells can be used by the family to treat future ailments since stem cells are the precursors to most specialized cells in the body and can be used to help treat a variety of illnesses.

View the Crioestaminal Video

Acquired:
October 2009
Industry:
Healthcare
Region:
Europe
Location:
Cantanhede, Portugal
Fund:
Riverside Europe Fund ( IV )
Add-on Acquisitions:

Celvitae Biomédica S.A. of Madrid, Spain (July 2010)

Website:
http://www.crioestaminal.pt/
News Releases:
Riverside Completes Its First Deal In Spain
Riverside Acquires Portuguese Provider of Cryopreservation and Isolation of Umbilical Cord Stem Cells